Insider trade

CEO sold ~$20.9M of ABT shares in the open market

Traded Aug 25, 2026 · Filed Aug 27, 2026

Why it stands out

The boss of Abbott Laboratories sold $20.9M of Abbott Laboratories shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

CEO$1M+

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$20,948,708

Shares × reported transaction price

Timing vs results

40 days after results of Jul 16, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.09 to $116.36, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.